Segment & Geographic Data
Quant-Grade Normalized Data
API & CSV Delivery
Global Cord Blood's Business Segments
Global Cord Blood's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Reportable Segments
-
Largest Segment
-
Total Revenue
-
Regions Reported
-
Annual Results
Revenue by Product & Service Category -
- Cord Blood Processing Fees0%
- Cord Blood Storage Fees0%
- Fees Derived From Provision of Donated Cord Blood6.4%
Revenue by Product & Service Category -
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Cord Blood Processing Fees | $ 693 | - |
| Cord Blood Storage Fees | $ 538 | - |
| Fees Derived From Provision of Donated Cord Blood | $ 12 | 6.4% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Description of Global Cord Blood
Global Cord Blood Corp.
is a company specialized in the collection, processing, and storage of umbilical cord blood stem cells.
These cells are obtained from the umbilical cord of newborn babies and used in treating various diseases, such as leukemia, sickle cell anemia, and other blood-related disorders.
The company was founded in 2008 and is headquartered in Hong Kong, with operations in China and other countries.
The company operates two main segments: cord blood storage services and hematopoietic stem cell transplantation services.
The cord blood storage services segment includes the collection, testing, processing, and storage of cord blood stem cells for future use.
The hematopoietic stem cell transplantation services segment involves providing cord blood stem cells for transplantation and coordinating the use of these cells for patients in need.
Global Cord Blood Corp has developed a strong reputation for quality and innovation in the cord blood banking industry.
The company maintains strict standards for the processing and storage of cord blood stem cells, and has earned accreditation from various international regulatory bodies.
The company is committed to providing affordable, high-quality cord blood banking services to families across the globe.
As of March 31, 2021, Global Cord Blood Corp had stored approximately 952,000 samples of cord blood from newborns.
The company's customer base includes individuals, families, and medical institutions.
Additionally, Global Cord Blood Corp has established partnerships with hospitals and research institutions to advance the use of cord blood stem cells in treatments for various diseases.
The company is publicly traded on the New York Stock Exchange under the symbol CO.
Global Cord Blood Corp is led by a team of experienced executives who are committed to the success of the company and its customers.
With its advanced technology, strict quality standards, and commitment to innovation, Global Cord Blood Corp is poised to remain a prominent player in the cord blood banking industry for years to come.
is a company specialized in the collection, processing, and storage of umbilical cord blood stem cells.
These cells are obtained from the umbilical cord of newborn babies and used in treating various diseases, such as leukemia, sickle cell anemia, and other blood-related disorders.
The company was founded in 2008 and is headquartered in Hong Kong, with operations in China and other countries.
The company operates two main segments: cord blood storage services and hematopoietic stem cell transplantation services.
The cord blood storage services segment includes the collection, testing, processing, and storage of cord blood stem cells for future use.
The hematopoietic stem cell transplantation services segment involves providing cord blood stem cells for transplantation and coordinating the use of these cells for patients in need.
Global Cord Blood Corp has developed a strong reputation for quality and innovation in the cord blood banking industry.
The company maintains strict standards for the processing and storage of cord blood stem cells, and has earned accreditation from various international regulatory bodies.
The company is committed to providing affordable, high-quality cord blood banking services to families across the globe.
As of March 31, 2021, Global Cord Blood Corp had stored approximately 952,000 samples of cord blood from newborns.
The company's customer base includes individuals, families, and medical institutions.
Additionally, Global Cord Blood Corp has established partnerships with hospitals and research institutions to advance the use of cord blood stem cells in treatments for various diseases.
The company is publicly traded on the New York Stock Exchange under the symbol CO.
Global Cord Blood Corp is led by a team of experienced executives who are committed to the success of the company and its customers.
With its advanced technology, strict quality standards, and commitment to innovation, Global Cord Blood Corp is poised to remain a prominent player in the cord blood banking industry for years to come.
Global Cord Blood Corporation (GCBC) is a prominent player in the field of cord blood banking, with a strong focus on the collection, processing, and storage of umbilical cord blood stem cells. The company operates primarily in two key segments: China and Hong Kong, where it offers a range of services designed to meet the needs of families and the broader medical community.
Segments
1. China:
- Presence and Market Leadership: GCBC has established a significant footprint in China, with its main operational hub located in Beijing. This position allows GCBC to cater to a large population that increasingly recognizes the importance of cord blood banking for future medical applications.
- Cord Blood Services: The company provides comprehensive cord blood collection, processing, and storage services for families wishing to preserve their newborns’ cord blood for potential future therapies.
- Public Cord Blood Bank: GCBC is also a pioneer in operating a public cord blood bank in China. This bank serves as a vital resource for those in need of stem cell transplants, facilitating the treatment of various conditions such as leukemia, thalassemia, and certain genetic disorders. The public bank not only helps generate a donor pool but also enhances accessibility for patients requiring these critical therapies.
2. Hong Kong:
- Operational Distinctiveness: In Hong Kong, GCBC operates as a separate entity with its own management team, reflecting the regulatory and market characteristics of the region.
- Umbilical Cord Blood Banking: Like its operations in China, GCBC offers similar services in Hong Kong, assuring families of high-quality collection, processing, and storage of cord blood. The services are tailored to meet local healthcare standards and family needs.
Products and Services
1. Cord Blood Collection:
- Professional Collection Services: GCBC provides dedicated services for the collection of cord blood at the time of birth. With trained medical personnel mobilized to hospitals or specific birthing locations, the company ensures a sterile and efficient collection process. Cord blood is collected using safe and standardized protocols to maximize the viability of stem cells.
2. Cord Blood Processing:
- State-of-the-Art Technology: Post-collection, cord blood undergoes rigorous processing using cutting-edge technology. The collected cells are meticulously tested to meet stringent quality standards before being prepared for storage. This phase often includes the isolation of stem cells and analysis to ensure their viability and functionality.
3. Cord Blood Storage:
- Cryopreservation Facilities: GCBC operates advanced facilities equipped with modern cryopreservation technology. The processed stem cells are stored in conducive conditions within sterile, single-use bags. The tanks used for storage are regularly monitored to maintain optimal temperatures and environmental conditions, ensuring the longevity of the stem cells.
4. Dual Storage:
- Enhanced Security Measures: To further safeguard the preserved stem cells, GCBC offers a dual storage option. This involves storing the samples in two distinct locations, which significantly reduces the risk of loss due to unforeseen circumstances, thus providing families with additional peace of mind.
5. Public Cord Blood Banking:
- Community Impact: The public cord blood bank managed by GCBC plays a crucial role in promoting community health. Parents who opt for donation can contribute to a public inventory that serves patients needing stem cell transplants across various medical conditions. This initiative supports the principle of altruism in healthcare while expanding access for those in critical need.
6. Genetic Testing and HLA Matching:
- Supporting Personalized Medicine: GCBC offers genetic testing services that can help families understand potential hereditary conditions. Additionally, HLA (Human Leukocyte Antigen) matching services ensure that stem cell donors and recipients are properly matched, improving the likelihood of successful transplants and treatment outcomes. These services are particularly valuable in the context of personalized medicine approaches.
Consultative Services:
- Family Support and Education: GCBC engages with families to educate them about the benefits of cord blood banking, the procedures involved, and potential medical applications. The organization provides consultative support to help prospective clients make informed decisions regarding their cord blood storage options.
In conclusion, Global Cord Blood Corporation offers a holistic suite of services focused on the preservation and utilization of umbilical cord blood stem cells. The companys operational strength in China and Hong Kong, combined with its commitment to quality and community support through public banking efforts, positions GCBC as a leader in the field. Its advanced technologies, strong focus on safety and security, as well as complementary services like genetic testing, underline its comprehensive approach to cord blood banking and stem cell preservation.
Segments
1. China:
- Presence and Market Leadership: GCBC has established a significant footprint in China, with its main operational hub located in Beijing. This position allows GCBC to cater to a large population that increasingly recognizes the importance of cord blood banking for future medical applications.
- Cord Blood Services: The company provides comprehensive cord blood collection, processing, and storage services for families wishing to preserve their newborns’ cord blood for potential future therapies.
- Public Cord Blood Bank: GCBC is also a pioneer in operating a public cord blood bank in China. This bank serves as a vital resource for those in need of stem cell transplants, facilitating the treatment of various conditions such as leukemia, thalassemia, and certain genetic disorders. The public bank not only helps generate a donor pool but also enhances accessibility for patients requiring these critical therapies.
2. Hong Kong:
- Operational Distinctiveness: In Hong Kong, GCBC operates as a separate entity with its own management team, reflecting the regulatory and market characteristics of the region.
- Umbilical Cord Blood Banking: Like its operations in China, GCBC offers similar services in Hong Kong, assuring families of high-quality collection, processing, and storage of cord blood. The services are tailored to meet local healthcare standards and family needs.
Products and Services
1. Cord Blood Collection:
- Professional Collection Services: GCBC provides dedicated services for the collection of cord blood at the time of birth. With trained medical personnel mobilized to hospitals or specific birthing locations, the company ensures a sterile and efficient collection process. Cord blood is collected using safe and standardized protocols to maximize the viability of stem cells.
2. Cord Blood Processing:
- State-of-the-Art Technology: Post-collection, cord blood undergoes rigorous processing using cutting-edge technology. The collected cells are meticulously tested to meet stringent quality standards before being prepared for storage. This phase often includes the isolation of stem cells and analysis to ensure their viability and functionality.
3. Cord Blood Storage:
- Cryopreservation Facilities: GCBC operates advanced facilities equipped with modern cryopreservation technology. The processed stem cells are stored in conducive conditions within sterile, single-use bags. The tanks used for storage are regularly monitored to maintain optimal temperatures and environmental conditions, ensuring the longevity of the stem cells.
4. Dual Storage:
- Enhanced Security Measures: To further safeguard the preserved stem cells, GCBC offers a dual storage option. This involves storing the samples in two distinct locations, which significantly reduces the risk of loss due to unforeseen circumstances, thus providing families with additional peace of mind.
5. Public Cord Blood Banking:
- Community Impact: The public cord blood bank managed by GCBC plays a crucial role in promoting community health. Parents who opt for donation can contribute to a public inventory that serves patients needing stem cell transplants across various medical conditions. This initiative supports the principle of altruism in healthcare while expanding access for those in critical need.
6. Genetic Testing and HLA Matching:
- Supporting Personalized Medicine: GCBC offers genetic testing services that can help families understand potential hereditary conditions. Additionally, HLA (Human Leukocyte Antigen) matching services ensure that stem cell donors and recipients are properly matched, improving the likelihood of successful transplants and treatment outcomes. These services are particularly valuable in the context of personalized medicine approaches.
Consultative Services:
- Family Support and Education: GCBC engages with families to educate them about the benefits of cord blood banking, the procedures involved, and potential medical applications. The organization provides consultative support to help prospective clients make informed decisions regarding their cord blood storage options.
In conclusion, Global Cord Blood Corporation offers a holistic suite of services focused on the preservation and utilization of umbilical cord blood stem cells. The companys operational strength in China and Hong Kong, combined with its commitment to quality and community support through public banking efforts, positions GCBC as a leader in the field. Its advanced technologies, strong focus on safety and security, as well as complementary services like genetic testing, underline its comprehensive approach to cord blood banking and stem cell preservation.